Real-world evaluation of compliance and preference in Alzheimer’s disease treatment

PURPOSE: Rivastigmine transdermal patch has shown higher caregiver satisfaction and greater preference than oral formulation in patients with Alzheimer’s disease. However, there is limited literature available related to caregiver preference or treatment compliance in real-world clinical settings. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Pai, Ming-Chyi, Aref, Hany, Bassil, Nazem, Kandiah, Nagaendran, Lee, Jae-Hong, Srinivasan, AV, diTommaso, Shelley, Yuksel, Ozgur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639476/
https://www.ncbi.nlm.nih.gov/pubmed/26622172
http://dx.doi.org/10.2147/CIA.S85319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639476/
https://www.ncbi.nlm.nih.gov/pubmed/26622172
http://dx.doi.org/10.2147/CIA.S85319

Ejemplares similares